Health
Tocilizumab cuts mortality risk in severely ill COVID-19 patients finds new trial conducted in India – Medical Xpress
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial…
Tocilizumab, an anti-inflammatory drug used to treat rheumatoid arthritis, improves outcomes in severely ill COVID-19 patients, finds the results of a new trial conducted in hospitals across Indiaone of the world’s most ethnically diverse countries. Researchers from the University of Bristol and Medanta Institute of Education and Research in India who led the study, published in The Lancet Respiratory Medicine, say it adds to existing evidence supporting the drug’s use in critically ill patients.
…
-
General23 hours agoWondering about winter | The Spectator Australia
-
Noosa News20 hours agoThis 42-Kilometre Walking Trail on the NSW North Coast Weaves Through Ancient Rainforest, Volcanic Mountains and Spectacular Waterfalls
-
Noosa News22 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
General22 hours agoParents of Heidi, 3, remember ‘beautiful’ daughter killed in Ocean Grove crash